簡介

本頁面提供了有關 James C Gale 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示James C Gale已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:TLGT / Teligent Inc Director, 10% Owner 17,515
US:XS1738994596 / Pfizer Inc Director 592,978
US:BJCT / Bioject Medical Technologies Inc. Director 0
如何解讀這些圖表

以下圖表顯示了在James C Gale進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 James C Gale 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2020-09-16 2020-08-26 4 TLGT Teligent, Inc.
Common Stock
S - Sale -85,106 17,515 -82.93 1.25 -106,195 21,855
2020-09-16 2020-08-26 4 TLGT Teligent, Inc.
Common Stock
S - Sale -475,512 98,390 -82.86 1.24 -591,299 122,348
2020-09-16 2020-08-25 4 TLGT Teligent, Inc.
Common Stock
S - Sale -15,184 102,621 -12.89 1.13 -17,106 115,613
2020-09-16 2020-08-25 4 TLGT Teligent, Inc.
Common Stock
S - Sale -84,816 573,902 -12.88 1.13 -96,147 650,575
2020-09-16 2020-08-21 4 TLGT Teligent, Inc.
Common Stock
S - Sale -18,432 117,805 -13.53 1.66 -30,540 195,191
2020-09-16 2020-08-21 4 TLGT Teligent, Inc.
Common Stock
S - Sale -102,962 658,718 -13.52 1.66 -171,071 1,094,460
2020-09-16 2020-08-19 4 TLGT Teligent, Inc.
Common Stock
S - Sale -13,251 136,237 -8.86 2.25 -29,760 305,975
2020-09-16 2020-08-19 4 TLGT Teligent, Inc.
Common Stock
S - Sale -74,020 761,680 -8.86 2.26 -167,026 1,718,731
2020-01-03 2020-01-02 4 TLGT Teligent, Inc.
Stock Option
A - Award 20,000 20,000
2019-10-04 2019-10-02 4 TLGT Teligent, Inc.
Stock Option
A - Award 10,653 10,653
2019-07-03 2019-07-01 4 TLGT Teligent, Inc.
Stock Option
A - Award 14,423 14,423
2019-05-31 2019-05-31 4 TLGT Teligent, Inc.
Common Stock
P - Purchase 20,000 394,624 5.34 0.66 13,166 259,781
2019-05-24 2019-05-23 4 TLGT Teligent, Inc.
Common Stock
P - Purchase 20,000 374,624 5.64 0.69 13,814 258,753
2019-05-15 2019-05-13 4 TLGT Teligent, Inc.
Stock Option
A - Award 10,901 10,901
2019-05-15 2019-05-13 4 TLGT Teligent, Inc.
Stock Option
A - Award 10,901 10,901
2019-01-04 2019-01-02 4 TLGT Teligent, Inc.
Stock Option
A - Award 20,000 20,000
2018-01-04 2018-01-02 4 TLGT Teligent, Inc.
Stock Option
A - Award 20,000 20,000
2017-11-13 2017-11-10 4 TLGT Teligent, Inc.
Common Stock
P - Purchase 15,000 354,624 4.42 3.81 57,136 1,350,798
2017-01-05 2017-01-03 4 TLGT Teligent, Inc.
Stock Option
A - Award 20,000 20,000
2016-03-14 2016-03-11 4 TLGT Teligent, Inc.
Common Stock
P - Purchase 15,000 25,000 150.00 4.91 73,718 122,862
2016-01-06 2016-01-04 4 TLGT Teligent, Inc.
Stock Option
A - Award 20,000 20,000
2016-01-06 2015-01-02 5 TLGT Teligent, Inc.
Stock Option (Right to Buy)
A - Award 35,000 35,000
2015-05-01 2015-04-30 4 IG IGI LABORATORIES, INC
Common Stock
P - Purchase 10,000 49,624 25.24 5.04 50,400 250,105
2015-05-01 2015-04-30 4 IG IGI LABORATORIES, INC
Common Stock
P - Purchase 20,000 39,624 101.92 5.04 100,800 199,705
2015-04-30 2015-04-29 4 PFNX Pfenex Inc.
Common Stock
S - Sale -330,959 592,978 -35.82 14.57 -4,822,073 8,639,689
2015-04-30 2015-04-29 4 PFNX Pfenex Inc.
Common Stock
S - Sale -1,576,808 1,818,339 -46.44 14.57 -22,974,093 26,493,199
2015-03-06 2015-03-05 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -1,696,320 8,356,988 -16.87 9.95 -16,878,384 83,152,031
2015-03-06 2015-03-05 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -303,680 1,494,873 -16.88 9.95 -3,021,616 14,873,986
2014-09-04 2014-09-02 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -1,696,500 10,053,308 -14.44 6.45 -10,942,425 64,843,837
2014-09-04 2014-09-02 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -303,500 1,798,553 -14.44 6.45 -1,957,575 11,600,667
2014-08-29 2014-08-27 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -2,544,743 11,749,808 -17.80 6.20 -15,777,407 72,848,810
2014-08-29 2014-08-27 4 IG IGI LABORATORIES, INC
Common Stock
S - Sale -455,257 2,102,053 -17.80 6.20 -2,822,593 13,032,729
2014-08-26 2014-08-22 4 IG IGI LABORATORIES, INC
Common Stock
P - Purchase 5,000 19,624 34.19 5.90 29,500 115,782
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Series A-2 Participating Preferred Stock
C - Conversion -2,515,903 0 -100.00
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Series A-2 Participating Preferred Stock
C - Conversion -684,665 0 -100.00
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
S - Sale -299,392 3,395,147 -8.10 0.31 -92,812 1,052,496
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
S - Sale -81,475 923,937 -8.10 0.31 -25,257 286,420
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
J - Other 525,509 3,694,539 16.58
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
J - Other 143,009 1,005,412 16.58
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
C - Conversion 2,869,638 3,169,030 958.49
2014-07-31 2014-07-29 4 PFNX Pfenex Inc.
Common Stock
C - Conversion 780,928 862,403 958.49
2014-07-17 3 PFNX Pfenex Inc.
Common Stock
462,342
2014-07-17 3 PFNX Pfenex Inc.
Common Stock
680,259
2014-07-17 3 PFNX Pfenex Inc.
Common Stock
462,342
2014-07-17 3 PFNX Pfenex Inc.
Common Stock
680,259
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
C - Conversion -656,306 0 -100.00
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
C - Conversion -207,255 0 -100.00
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series I Convertible Preferred Stock
J - Other 23,095 23,095 10.00 230,950 230,950
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Convertible Preferred Stock
C - Conversion -82,900 0 -100.00 13.00 -1,077,700
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
C - Conversion -1,820,483 0 -100.00
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series D Convertible Preferred Stock
C - Conversion -1,770,073 0 -100.00 1.15 -2,035,584
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series I Convertible Preferred Stock
J - Other 4,135 4,135 10.00 41,350 41,350
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Convertible Preferred Stock
C - Conversion -14,821 0 -100.00 13.00 -192,673
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
C - Conversion -325,908 0 -100.00
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series D Convertible Preferred Stock
C - Conversion -316,884 0 -100.00 1.15 -364,417
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 656,306 656,306
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 207,255 207,255
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 8,290,002 11,962,566 225.73
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 1,820,483 3,672,564 98.29
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 1,770,073 1,852,081 2,158.42
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 1,482,067 2,139,543 225.42
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 325,908 657,473 98.29
2014-06-05 2014-04-30 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Common Stock
C - Conversion 316,884 331,565 2,158.46
2014-01-06 2014-01-02 4 IG IGI LABORATORIES, INC
Stock Option
A - Award 15,000 15,000
2013-03-15 2013-03-13 4 IG IGI LABORATORIES, INC
Common Stock
P - Purchase 10,000 14,624 216.26 1.33 13,265 19,399
2013-03-15 2013-01-02 4 IG IGI LABORATORIES, INC
Stock Option
A - Award 15,000 15,000
2013-02-19 2013-01-11 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Preferred Stock
J - Other 15,258 65,593 30.31
2013-02-19 2013-01-11 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Preferred Stock
J - Other 2,732 13,473 25.44
2013-02-19 2008-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 48,615 607,691 8.70
2013-02-19 2008-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 15,352 207,255 8.00
2013-02-19 2008-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 134,698 1,818,423 8.00
2013-02-19 2008-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 24,114 325,539 8.00
2013-02-19 2007-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 45,104 559,076 8.78
2013-02-19 2007-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 14,215 191,903 8.00
2013-02-19 2007-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 124,720 1,683,725 8.00
2013-02-19 2007-06-01 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series E Convertible Preferred Stock
J - Other 22,328 301,425 8.00
2013-02-06 2013-01-24 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series H Preferred Stock
P - Purchase 63,612 63,612 10.00 636,120 636,120
2013-02-06 2013-01-24 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series H Preferred Stock
P - Purchase 11,388 11,388 10.00 113,880 113,880
2013-02-05 2009-12-18 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Convertible Note
J - Other 0
2013-02-05 2009-12-18 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Convertible Note
J - Other 0
2013-02-05 2009-12-18 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Preferred Stock
J - Other 44,323 44,323 13.00 576,199 576,199
2013-02-05 2009-12-18 4 BJCT BIOJECT MEDICAL TECHNOLOGIES INC
Series G Preferred Stock
J - Other 9,665 9,665 13.00 125,645 125,645
2012-01-06 2012-01-03 4 IG IGI LABORATORIES, INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)